Immunosuppression and Chagas Disease: A Management Challenge

PLoS Neglected Tropical Diseases

Volumn 7, Issue 1, 2013, Pages

  Pinazo, María Jesús ^a   Espinosa, Gerard ^b   Cortes Lletget, Cristina ^c   de Posada, Elizabeth Jesús ^a   Aldasoro, Edelweiss ^a   Oliveira, Inés ^a   Muñoz, Jose ^a   Gállego, Montserrat ^a   Gascon, Joaquim ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL GENERAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; NIFURTIMOX; POSACONAZOLE; PREDNISONE;

ADULT; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNOLOGICAL MONITORING; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OPPORTUNISTIC INFECTION; PARASITEMIA; POLYMERASE CHAIN REACTION; REVIEW; TRYPANOSOMA CRUZI; VIRUS LOAD;

EID: 84873512107     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001965     Document Type: Review

References (67)

1. UNAIDS WHO (2009) AIDS epidemic update. UNAIDS/09.36E/JC1700E.
2. da Costa SC, (2000) Immunocompromised host: from the early events until the impact of acquired immunodeficiency syndrome. Mem Inst Oswaldo Cruz 95 (Suppl 1): 141-144.
3. Gascon J, Bern C, Pinazo MJ, (2010) Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 115: 22-27.
4. World Health Organization (WHO) (2010) Control and prevention of Chagas disease in Europe. Report of a WHO Informal Consultation (jointly organized by WHO headquarters and the WHO Regional Office for Europe). WHO/HTM/NTD/IDM/2010.1.2010. WHO: Geneva.
5. Ferreira MS, Borges AS, (2002) Some aspects of protozoan infections in immunocompromised patients - a review. Mem Inst Oswaldo Cruz 97: 443-457.
6. Almeida EA, Lima JN, Lages-Silva E, Guariento ME, Aoki FH, et al. (2010) Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg 104: 447-452.
7. Sartori AM, Shikanai-Yasuda MA, Amato Neto V, Lopes MH, (1998) Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin Infect Dis 26: 177-179.
8. Sartori AM, Lopes MH, Caramelli B, Duarte MI, Pinto PL, et al. (1995) Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS. Clin Infect Dis 21: 1297-1299.
9. Campos SV, Strabelli TM, Amato Neto V, Silva CP, Bacal F, et al. (2008) Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 27: 597-602.
10. Bocchi EA, Bellotti G, Uip D, Kalil J, de Lourdes Higuchi M, et al. (1993) Long-term follow-up after heart transplantation in Chagas' disease. Transplant Proc 25: 1329-1330.
11. Stolf NA, Higushi L, Bocchi E, Bellotti G, Auler JO, et al. (1987) Heart transplantation in patients with Chagas' disease cardiomyopathy. J Heart Transplant 6: 307-312.
12. d'Avila SC, d'Avila AM, Pagliari C, Goncalves VM, Duarte MI, (2005) Erythema nodoso in reactivation of Chagas' disease after cardiac transplantation. Rev Soc Bras Med Trop 38: 61-63.
13. Vaidian AK, Weiss LM, Tanowitz HB, (2004) Chagas' disease and AIDS. Kinetoplastid Biol Dis 13 3: 2.
14. Altclas JD, Barcan L, Nagel C, Lattes R, Riarte A, (2008) Organ transplantation and Chagas disease. JAMA 299: 1134-1135.
15. Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M, (2008) Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis 12: 587-592.
16. Sartori AM, Ibrahim KY, Nunes Westphalen EV, Braz LM, Oliveira OC Jr, et al. (2007) Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 101: 31-50.
17. Le Loup G, Pialoux G, Lescure FX, (2011) Update in treatment of Chagas disease. Curr Opin Infect Dis 24: 428-434.
18. Secretaria de Vigilância em Saúde do Ministério da Saúde (2005) Consenso brasileiro em doença de Chagas. Rev Soc Bras Med Trop 38: 1-29.
19. Pinazo MJ, Miranda B, Rodriguez-Villar C, Altclas J, Brunet-Serra M, et al. (2011) Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev 25: 91-101.
20. Perez-Molina JA, Rodriguez-Guardado A, Soriano A, Pinazo MJ, Carrilero B, et al. (2011) Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areas. HIV Clin Trials 12: 287-298.
21. Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, et al. (1994) Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261-268.
22. Corti M, (2000) AIDS and Chagas' disease. AIDS Patient Care STDS 14: 581-588.
23. Organización Panamericana de la Salud (OPS/OMS) (2009) Definición de la OMS de caso de infección por el VIH a efectos de vigilancia y revisión de la estadifi cación clínica y de la clasificación inmunológica de la enfermedad relacionada con el VIH en adultos y niños. OPS/FCH/HI/04-09.E.
24. Del Castillo M, Mendoza G, Oviedo J, Perez Bianco RP, Anselmo AE, et al. (1990) AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med 88: 693-694.
25. del Castillo M, Silva M, (1994) Chagas disease: another cause of cerebral mass in AIDS. Am J Med 96: 301-302.
26. Ferreira MS, Nishioka S de A, Silvestre MT, Borges AS, Nunes-Araujo FR, et al. (1997) Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 25: 1397-1400.
27. Gluckstein D, Ciferri F, Ruskin J, (1992) Chagas' disease: another cause of cerebral mass in the acquired immunodeficiency syndrome. Am J Med 92: 429-432.
28. Perez-Ramirez L, Barnabe C, Sartori AM, Ferreira MS, Tolezano JE, et al. (1999) Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil. Am J Trop Med Hyg 61: 198-206.
29. Sartori AM, Neto JE, Nunes EV, Braz LM, Caiaffa-Filho HH, et al. (2002) Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis 186: 872-875.
30. de Freitas VL dSS, Sartori AM, Bezerra RC, Westphalen EV, Molina TD, Teixeira AR, Ibrahim KY, Shikanai-Yasuda MA, (2011) Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level. PLoS Negl Trop Dis 5 (8): e1277 doi:10.1371/journal.pntd.0001277.
31. Sica RE, Gargiullo G, Papayanis C, (2008) Tumour-like chagasic encephalitis in AIDS patients: an atypical presentation in one of them and outcome in a small series of cases. Arq Neuropsiquiatr 66: 881-884.
32. Montero A, Cohen JE, Martinez DP, Giovannoni AG, (1998) Empirical anti-toxoplasma therapy in cerebral AIDS and Chagas disease. Presentation of 2 cases, review of the literature and proposal of an algorithm. Medicina 58: 504-506.
33. Pacheco RS, Ferreira MS, Machado MI, Brito CM, Pires MQ, et al. (1998) Chagas' disease and HIV co-infection: genotypic characterization of the Trypanosoma cruzi strain. Mem Inst Oswaldo Cruz 93: 165-169.
34. Silva AA, Roffe E, Marino AP, dos Santos PV, Quirico-Santos T, et al. (1999) Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens. Clin Immunol 92: 56-66.
35. Yoo TW, Mlikotic A, Cornford ME, Beck CK, (2004) Concurrent cerebral american trypanosomiasis and toxoplasmosis in a patient with AIDS. Clin Infect Dis 39: e30-34.
36. Madalosso G, Pellini AC, Vasconcelos MJ, Ribeiro AF, Weissmann L, et al. (2004) Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil. Rev Inst Med Trop Sao Paulo 46: 199-202.
37. Galhardo MC, Martins IA, Hasslocher-Moreno A, Xavier SS, Coelho JM, et al. (1999) Reactivation of Trypanosoma cruzi infection in patients with acquired immunodeficiency syndrome. Rev Soc Bras Med Trop 32: 291-294.
38. Lages-Silva E, Ramirez LE, Silva-Vergara ML, Chiari E, (2002) Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis 34: 118-123.
39. Pagano MA, Segura MJ, Di Lorenzo GA, Garau ML, Molina HA, et al. (1999) Cerebral tumor-like American trypanosomiasis in acquired immunodeficiency syndrome. Ann Neurol 45: 403-406.
40. Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, et al. (2009) Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 9: 324-330.
41. Kirchhoff LV, Weiss LM, Wittner M, Tanowitz HB, (2004) Parasitic diseases of the heart. Front Biosci 9: 706-723.
42. Rivera J, Hillis LD, Levine BD, (2004) Reactivation of cardiac Chagas' disease in acquired immune deficiency syndrome. Am J Cardiol 94: 1102-1103.
43. Sartori AM, Lopes MH, Benvenuti LA, Caramelli B, di Pietro A, et al. (1998) Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. T Am J Trop Med Hyg 59: 784-786.
44. Cahn P BR, Freilij H (2001) Other parasitic infections. In: Crowe S HJ, Mills J, editor. Management of the HIV-infected patient. 2nd ed. London, UK: Taylor & Francis Group. pp. 513-525.
45. Iliovich E, Lopez R, Kum M, Uzandizaga G, (1998) Spontaneous chagasic peritonitis in a patient with AIDS. Medicina 58: 507-508.
46. Sartori AM, Sotto MN, Braz LM, Oliveira Junior O da C, Patzina RA, et al. (1999) Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg 93: 631-632.
47. Concetti H, Retegui M, Perez G, Perez H, (2000) Chagas' disease of the cervix uteri in a patient with acquired immunodeficiency syndrome. Hum Pathol 31: 120-122.
48. Solari A, Saavedra H, Sepulveda C, Oddo D, Acuna G, et al. (1993) Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. Clin Infect Dis 16: 255-259.
49. Braz LM, Amato Neto V, Carignani FL, De Marchi CR, (2001) Trypanosoma cruzi parasitemia observed in immunocompromised patients: the importance of the artificial xenodiagnosis. Rev Inst Med Trop Sao Paulo 43: 113-115.
50. Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, et al. (2011) International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis 5: e931 doi:10.1371/journal.pntd.0000931.
51. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, et al. (2007) Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 298: 2171-2181.
52. Rodriques Coura J, de Castro SL, (2002) A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3-24.
53. Andrade SG, Mesquita IM, Jambeiro JF, Santos IF, Portella RS, (2003) Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias. Rev Soc Bras Med Trop 36: 441-447.
54. Cançado JRCM, (1985) Tratamento especifico Cardiopatia Chagásica. 1st ed: Fundação Carlos Chagas de Pesquisa Médica pp. 327-355.
55. Murta EF, Oliveira GP, Prado Fde O, De Souza MA, Tavares Murta BM, et al. (2002) Association of uterine leiomyoma and Chagas' disease. Am J Trop Med Hyg 66: 321-324.
56. Rocha A, Almeida HO Esper FE, Moraes DM, Santos EP, et al. (1983) Associacao entre megaesofago e carcinoma de esofago. Rev Soc Bras Med Trop 16: 94-97.
57. Oliveira EC, Lette MS, Ostermayer AL, Almeida AC, Moreira H, (1997) Chagasic megacolon associated with colon cancer. Am J Trop Med Hyg 56: 596-598.
58. Adad SJ, Etchebehere RM, Araujo JR, Madureira AB, Lima VG, et al. (2002) Association of chagasic megacolon and cancer of the colon: case report and review of the literature. Rev Soc Bras Med Trop 35: 63-68.
59. Garcia SB, Oliveira JS, Pinto LZ, Muccillo G, Zucoloto S, (1996) The relationship between megacolon and carcinoma of the colon: an experimental approach. Carcinogenesis 17: 1777-1779.
60. Barousse AP, Costa JA, Eposto M, Laplume H, Segura EL, (1980) Chagas disease and immunosuppression. Medicina 40 (Suppl 1): 17-26.
61. dos Santos-Neto LL, Polcheira MF, Castro C, Lima RA, Simaan CK, et al. (2003) Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus. Rev Soc Bras Med Trop 36: 613-615.
62. Pinazo MJ, Espinosa G, Gallego M, Lopez-Chejade PL, Urbina JA, et al. (2010) Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg 82: 583-587.
63. Cossermelli W, Friedman H, Pastor EH, Nobre MR, Manzione A, et al. (1978) Polymyositis in Chagas's disease. Ann Rheum Dis 37: 277-280.
64. Nishioka S de A, (2000) Benznidazole in the primary chemoprophylaxis of the reactivation of Chagas' disease in chronic chagasic patients using corticosteroids at immunosuppressive doses: is there sufficient evidence for recommending its use? Rev Soc Bras Med Trop 33: 83-85.
65. Rassi A, Amato Neto V, de Siqueira AF, Ferriolli Filho F, Amato VS, et al. (1999) Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases. Rev Soc Bras Med Trop 32: 475-482.
66. Tresoldi AT, Belangero VM, da Silva MT, Netto AA, Marques MC, Mezzacappa MA, et al. (1984) Doença de Chagas congênita: reagudização pela corticoterapia. Pediatr (São Paulo) 6: 207-210.
67. Kuschnir E, Sgammini H, Castro R, Evequoz C, Ledesma R, et al. (1985) Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy. Arq Bras Cardiol 45: 249-256.